Back to results
US 2016/0030545 A1Published application
Neisseria meningitidis antigens and compositions
AssigneeGlaxosmithkline Biologicals SA
InventorsClaire FRASER, Cesira GALEOTTI, Guido GRANDI, Erin HICKEY, Vega MASIGNANI, Marirosa MORA, Jeremy PETERSEN, Mariagrazia PIZZA, Rino RAPPUOLI, Giulio RATTI, Vincenzo SCARLATO, Maria SCARSELLI, Herve TETTELIN, J. Craig VENTER
Life of this patent
Estimating the term…
Abstract
The invention provides proteins from Neisseria meningitidis, including the amino acid sequences and the corresponding nucleotide sequences. The proteins are predicted to be useful antigens for vaccines and/or diagnostics.
Claims17
(canceled)
A protein comprising (i) a fragment of at least seven consecutive amino acids from an amino acid sequence selected from the group consisting of SEQ ID NO:
- 2916;
- SEQ ID NO:
- 2918, and SEQ ID NO:
- 2920, or (ii) an amino acid sequence having at least 80% identity to one of SEQ ID NO:
- 2916;
- SEQ ID NO:
- 2918, and SEQ ID NO:
- 2920.
5 more elements
Dependencies are inferred from the claim text.